DBS raises Raffles Medical Group’s TP to $1.81, estimates FY2022-2023 earnings could hit record high

DBS Group Research analyst Rachel Tan has kept “buy” on Raffles Medical Group with a raised target price of $1.81 from $1.48. The higher sum-of-the-parts target price took into consideration the …
( read original story …)

---

Search your Hotel